Home › Bleeding › Illinois › Chicago
Bleeding clinical trials in Chicago, IL
6 studies for Bleeding are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Onyx™ Liquid Embolic IDE Clinical Study
Recruiting
- University of Chicago, Chicago
Oxytocin Pharmacokinetics and Pharmacodynamics
RecruitingPhase 2
- University of Chicago, Chicago
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
RecruitingPhase 3
- University Of Chicago, Chicago
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
RecruitingPhase 4Healthy volunteers welcome
- Rush University Medical Center, Chicago
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RecruitingPhase 4
- University of Chicago, Chicago
MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
RecruitingObservational study
- CorVita Science Foundation (NFP), Chicago
About Bleeding
Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.
More about Bleeding on MedlinePlus
Bleeding trials in other cities
- Boston, MA10 studies
- New York City, NY8 studies
- Houston, TX7 studies
- Atlanta, GA6 studies
- Cleveland, OH6 studies
- Philadelphia, PA5 studies
- Durham, NC5 studies
- Seattle, WA5 studies
- St. Louis, MO5 studies
- San Diego, CA4 studies
- Cedar Rapids, IA4 studies
- Washington, DC4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)53 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity42 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.